Ayden Scheim

PhD

Associate Scientist, Li Ka Shing Knowledge Institute

Biography

Please note Dr. Scheim will not be taking any summer students in 2019.

Dr. Scheim is an Associate Scientist with the Centre on Drug Policy Evaluation, Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute. He is also a CIHR Postdoctoral Fellow in the Division of Infectious Diseases and Global Public Health at the University of California, San Diego. He holds a Ph.D. (2017) in Epidemiology and Biostatistics from Western University, where he was a Pierre Elliott Trudeau Foundation Scholar and Vanier Canada Graduate Scholar. Dr. Scheim investigates the impacts of social, policy, and healthcare environments on the health of stigmatized populations. In particular, his research program involves community-engaged research with transgender populations and marginalized people who use drugs, both domestically and globally.

Recent Publications

  1. Scheim, AI, Bauer, GR. The Intersectional Discrimination Index: Development and validation of measures of self-reported enacted and anticipated discrimination for intercategorical analysis. Soc Sci Med. 2019; :. doi: 10.1016/j.socscimed.2018.12.016. PubMed PMID:30674436 .
  2. Bauer, GR, Scheim, AI. Methods for analytic intercategorical intersectionality in quantitative research: Discrimination as a mediator of health inequalities. Soc Sci Med. 2018; :. doi: 10.1016/j.socscimed.2018.12.015. PubMed PMID:30674435 .
  3. Meyers, SA, Scheim, A, Jain, S, Sun, X, Milloy, MJ, DeBeck, K et al.. Gender differences in the provision of injection initiation assistance: a comparison of three North American settings. Harm Reduct J. 2018;15 (1):59. doi: 10.1186/s12954-018-0270-6. PubMed PMID:30514384 PubMed Central PMC6280353.
  4. Leonardi, M, Frecker, H, Scheim, AI, Kives, S. Reproductive Health Considerations in Sexual and/or Gender Minority Adolescents. J Pediatr Adolesc Gynecol. 2019;32 (1):15-20. doi: 10.1016/j.jpag.2018.09.010. PubMed PMID:30317009 .
  5. Scheim, A, Werb, D. Integrating supervised consumption into a continuum of care for people who use drugs. CMAJ. 2018;190 (31):E921-E922. doi: 10.1503/cmaj.180824. PubMed PMID:30087127 PubMed Central PMC6078768.
  6. Scheim, AI, Bardwell, G, Rachlis, B, Mitra, S, Kerr, T. Syringe sharing among people who inject drugs in London, Canada. Can J Public Health. 2018;109 (2):174-182. doi: 10.17269/s41997-018-0058-1. PubMed PMID:29981046 .
  7. Scheim, AI, Nosova, E, Knight, R, Hayashi, K, Kerr, T. HIV Incidence Among Men Who Have Sex with Men and Inject Drugs in a Canadian Setting. AIDS Behav. 2018;22 (12):3957-3961. doi: 10.1007/s10461-018-2185-3. PubMed PMID:29876756 PubMed Central PMC6281854.
  8. Kennedy, MC, Scheim, A, Rachlis, B, Mitra, S, Bardwell, G, Rourke, S et al.. Willingness to use drug checking within future supervised injection services among people who inject drugs in a mid-sized Canadian city. Drug Alcohol Depend. 2018;185 :248-252. doi: 10.1016/j.drugalcdep.2017.12.026. PubMed PMID:29475198 .
  9. Scheim, AI, Bauer, GR. Sexual Inactivity Among Transfeminine Persons: A Canadian Respondent-Driven Sampling Survey. J Sex Res. 2019;56 (2):264-271. doi: 10.1080/00224499.2017.1399334. PubMed PMID:29190148 .
  10. Poteat, T, Malik, M, Scheim, A, Elliott, A. Erratum to: HIV Prevention Among Transgender Populations: Knowledge Gaps and Evidence for Action. Curr HIV/AIDS Rep. 2017;14 (5):200. doi: 10.1007/s11904-017-0365-9. PubMed PMID:28905274 .
Search PubMed

Affiliations & Other Activities

Postdoctoral Fellow, University of California San Diego

X